cetuximab,afatinib,pembrolizumab,adagrasib
eli lilly,mirati,mirati,merck,boehringer ingelheim
['krystal-1', 'solid tumor', 'adagrasib', 'mirati']
encore starting at 12:30pm including: update on krystal-1 activity and safety of adagrasib in adv solid tumors harboring a krasg12c mutatuon with at #asco23 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how HCPs stay up-to-date.